NCT07042841Enrolling by invitation
AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer
the Study on AI-Integrated Fully Quantitative Treatment Decision and Surgical Planning System for Liver Cancer
Source: ClinicalTrials.gov · Last updated 29 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to develop and validate an integrated AI-powered system for liver cancer that includes intelligent tumor boundary detection, micro-metastasis prediction, staging, treatment decision-making, and surgical planning. The system builds upon prior 3D reconstructions of liver, vessels, and bile ducts. In a retrospective multi-center, self-controlled, fully crossed multi-reader multi-case clinical trial, the researchers will compare diagnostic accuracy, staging, and planning performance between AI-assisted reads and conventional reads using CT images and pathological gold standards.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 18 Jun 2025
- Start date
- 30 Jun 2015
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07042841
What you commit to
- Study type: Observational
- Planned participants: 300
- From 30 Jun 2015 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Incomplete liver coverage in CT images. 2. Severe noise artifacts in CT images. 3. History of liver resection or significant anatomical/volume alterations of the liver. 4. Deemed unsuitable for inclusion by the investigator.
Who the study is looking for
- 1\. Dynamic contrast-enhanced CT scan of the liver is available. 2. Age ≥ 18 years. 3. CT image slice thickness ≤ 5 mm. 4. An official CT report is available. 5. Meets at least one of the following subcategories:HCC-positive with liver lesion: CT report suggests suspected hepatocellular carcinoma (HCC), and complete hospitalization records are available to assess CNLC staging (including performance status, Child-Pugh classification, and extrahepatic metastasis). HCC-negative with liver lesion: CT report indicates at least one liver-occupying lesion, but not suspected to be HCC. No liver lesion: CT report indicates no liver-occupying lesion.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Tsinghua Chang Gung Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.